Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Renal osteodystrophy in chronic kidney disease (CKD) results from changes in calcium and phosphate metabolism, and altered parathyroid hormone and vitamin D levels. In the background of renal osteodystrophy and the increased risk of CKD patients for falls, these patients have a higher risk for fractures. Although bone biopsy and bone mineral density testing are used to test for renal osteodystrophy and osteoporosis, respectively, these tests are not frequently employed. The FRAX score is a computerized algorithm, which utilizes the patient’s general data and family history to calculate the 10-year probability of a fracture. Additionally, serum calcium and serum phosphorus levels, which are routinely monitored in hemodialysis patients, may also offer insights into the patient’s fracture risk.
This single-center, retrospective, cross-sectional study investigated 88 hemodialysis patients who had a history of fall. Descriptive analysis was used on the population’s characteristics. A logistic regression analysis was done on the FRAX score, calcium, and phosphorus levels to determine its likelihood in predicting fracture risk.
Among the risk factors for fractures included in the FRAX score, only glucocorticoid use was found to have a significant association with fracture risk (p = 0.007). The mean FRAX score for major osteoporotic fracture among patients with fractures was 5.0, compared to the mean FRAX score of 4.5 in patients without fractures, however, this difference was not statistically significant. On logistic regression analysis, the FRAX score for major osteoporotic fracture was the only predictor significantly associated with fractures, with a p-value of 0.037.
Among the assessed factors–FRAX score, serum calcium, and serum phosphorus–only FRAX score for major osteoporotic fractures effectively predicts fracture risk in ESRD patients undergoing maintenance hemodialysis after a fall. Notably, calcium and phosphorus levels did not show a significant correlation with fracture risk.
